At Klinic, we strive to prioritize your health goals through expert care, insurance support, and streamlined processes, including managing the prior authorization process for you
Your doctor will help find the best treatment, gradually increasing the dosage for weight loss and comfort
GLP-1R-targeted therapies have now expanded from metabolic diseases to AD
Retatrutide is not currently positioned as a routine, commercially available prescription medication, which means there is no standardised pricing structure to reference
In terms of duration of action, exenatide and lixisenatide are considered short-acting GLP-1 receptor agonists with a half-life of approximately 25 h, while dulaglutide, liraglutide and exenatide-LAR are considered long-acting GLP-1 receptor agonists with a half-life of 12 hseveral days